Leukocyte reduction of blood components: public policy and new technology (Q33835138)

29 July 2017

1 reference

title

Leukocyte reduction of blood components: public policy and new technology (English)

1 reference

29 July 2017

5

Manno C

2 references

ORCID Public Data File 2021

29 July 2017

10

Slichter SJ

1 reference

29 July 2017

Dzik S

1

1 reference

29 July 2017

Aubuchon J

2

1 reference

29 July 2017

Jeffries L

3

1 reference

29 July 2017

Kleinman S

4

1 reference

29 July 2017

Murphy MF

6

1 reference

29 July 2017

Popovsky MA

7

1 reference

29 July 2017

Sayers M

8

1 reference

29 July 2017

Silberstein LE

9

1 reference

29 July 2017

Vamvakas EC

11

1 reference

29 July 2017

publication date

1 January 2000

1 reference

Transfusion Medicine Reviews

29 July 2017

published in

1 reference

29 July 2017

volume

14

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

34-52

1 reference

The preparation of leukocyte-poor red cells for transfusion by a simple cost-effective technique

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Limited efficacy of leukopoor platelets for prevention of febrile transfusion reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Prevalence of platelet transfusion reactions before and after implementation of leukocyte-depleted platelet concentrates by filtration

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

The role of the plasma from platelet concentrates in transfusion reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Reactions to platelet transfusion: the effect of the storage time of the concentrate

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

The relationship between the duration of platelet storage and the development of transfusion reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Relationship of the time of storage and transfusion reactions to platelet concentrates from buffy coats

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF alpha and IL-6 levels and febrile transfusion reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Cytokine generation in stored platelet concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Low cytokine contamination in buffy coat-derived platelet concentrates without filtration

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Cytokines in platelet concentrates prepared from pooled buffy coats

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Chemokines in stored platelet concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

The efficacy of leukodepletion to improve platelet transfusion response: a critical appraisal of clinical studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Polymerase chain reaction for detection of human cytomegalovirus infection in a blood donor population

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Detection of cytomegalovirus in blood donors by the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Detection of human cytomegalovirus DNA, RNA, and antibody in normal donor blood

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

The presence of free infectious cytomegalovirus (CMV) in the plasma of donated CMV-seropositive blood and platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Blood transfusions and prognosis in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Blood transfusions and local tumor recurrence in colorectal cancer. Evidence of a noncausal relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: do we have the answers yet?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Blood donations and viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. Transfusion Safety Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Transmissible spongiform encephalopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Can Creutzfeldt-Jakob disease be transmitted by transfusion?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Creutzfeldt-Jakob disease and blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

B lymphocytes and neuroinvasion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

A crucial role for B cells in neuroinvasive scrapie.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Prion disease and blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Creutzfeldt-Jakob disease and transfusion safety: tilting at icebergs?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Creutzfeldt-Jakob disease and the risk from blood or blood products

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Transmission of Creutzfeldt-Jakob disease by blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Pooled plasma derivatives and Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Hypotensive reactions associated with platelet transfusions and angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Hypotensive reactions with a white cell-reduction filter: activation of kallikrein-kinin cascade in a patient

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

More on kininogen measurements in platelet concentrates that are white cell (WBC) reduced with WBC-reduction filters

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Bradykinin generation during filtration of platelet concentrates with a white cell-reduction filter

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Kinetics of bradykinin levels during and after leucocyte filtration of platelet concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Hypotensive reactions to red cells filtered at the bedside, but not to those filtered before storage, in patients taking ACE inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Transfusion practices in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Leukocyte Depletion of Red Cell Concentrates by Filtration: Influence of Blood Product Temperature

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Inadequate white cell reduction by bedside filtration of red cell concentrates.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Factors influencing white cell removal from red cell concentrates by filtration.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Optimal conditions for white cell reduction in red cells by filtration at the patient's bedside

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Six filters for the removal of white cells from red cell concentrates, evaluated at 4 degrees C and/or at room temperature

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Effect of filtration and storage of platelet concentrates on the production of the chemotaxins C5a, interleukin 8, tumor necrosis factor alpha, and leukotriene B4

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Practical guidelines for process validation and process control of white cell-reduced blood components: report of the Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT)

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Principles of counting low numbers of leukocytes in leukoreduced blood components

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Cost-effectiveness of white cell-reduction filters in treatment of adult acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Leukodepleted-ABO-identical blood components in the treatment of hematologic malignancies: a cost analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Leukocyte-depleted blood components prevent platelet refractoriness in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Modifying risk for extracorporeal circulation: trial of four antiinflammatory strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Cost-effectiveness of blood transfusion and white cell reduction in elective colorectal surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

The cost effectiveness of preoperative autologous blood donations

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Use of leucocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimmunization

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components--a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2800%2980114-5

7 January 2021

10.1016/S0887-7963(00)80114-5

Identifiers

DOI

1 reference

29 July 2017

1 reference